Volume | 111 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Alcon Inc | ALC | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
88.70 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
4 | 111 | - | 69.44 - 90.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
04:25:41 | 32 | $ 90.58 | USD |
Alcon Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
44.32B | 499.70M | - | 9.46B | 974M | 1.95 | 45.51 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Alcon News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALC Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 89.90 | 90.00 | 87.865 | 89.10 | 869,509 | -1.20 | -1.33% |
1 Month | 80.28 | 90.00 | 77.54 | 83.29 | 885,068 | 8.42 | 10.49% |
3 Months | 84.50 | 90.00 | 77.54 | 83.74 | 932,282 | 4.20 | 4.97% |
6 Months | 73.17 | 90.00 | 71.455 | 80.21 | 865,291 | 15.53 | 21.22% |
1 Year | 81.29 | 90.00 | 69.44 | 79.29 | 802,236 | 7.41 | 9.12% |
3 Years | 68.86 | 90.00 | 55.21 | 74.62 | 857,221 | 19.84 | 28.81% |
5 Years | 58.59 | 90.00 | 39.37 | 67.77 | 967,820 | 30.11 | 51.39% |
Alcon Description
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan. |